New drugs for the management of tuberculosis. [PDF]
Curr Opin Infect DisCross GB.
europepmc +1 more source
In Vitro Activities of Oxazolidinone Antibiotics Alone and in Combination with C-TEMPO against Methicillin-Resistant Staphylococcus aureus Biofilms. [PDF]
Antibiotics (Basel), 2023 Ndukwe ARN +5 more
europepmc +1 more source
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
J Clin Tuberc Other Mycobact DisTimboe K, Jackson JB, Becker GL.
europepmc +1 more source
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. [PDF]
Nat CommunChen X +13 more
europepmc +1 more source
The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis. [PDF]
Drugs, 2022 Edwards BD, Field SK.
europepmc +1 more source
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies. [PDF]
J Med ChemKovar O +7 more
europepmc +1 more source
Intellectual Property Rights Protection and Health: the Case of Tubercolosis [PDF]
, 2021 Sara Pau, Silvana Robone, Silvia Balia
core
Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review. [PDF]
GMS Hyg Infect ControlMichalik M +7 more
europepmc +1 more source
Stability-Indicating Assay of Novel 5-(Hydroxamic acid)methyl Oxazolidinones with 5-Lipooxygenase Inhibitory Activity. [PDF]
Pharmaceuticals (Basel)Al-Mutairi HM +2 more
europepmc +1 more source